Health By Nicholas Florko ‘Too little too late’: Unpacking Biden’s moves to improve federal prisons’ response to Covid-19
Politics By Lev Facher Francis Collins: Concern about independence of new moonshot science agency ARPA-H are ‘overblown’
Hospitals By Tara Bannow Justice Department says sweeping lab test fraud in Texas involved dozens of doctors and front companies
Politics By Rachel Cohrs Biden administration won’t lower seniors’ Medicare premiums this year, despite changes to coverage of new Alzheimer’s drug
Exclusive By Rachel Cohrs Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb
Hospitals By Tara Bannow The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it
D.C. Diagnosis By Nicholas Florko As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
Politics By Lev Facher The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years
Exclusive By Nicholas Florko Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs
Politics By Rachel Cohrs Manchin won’t support new health policy unless Congress rolls back Trump tax cuts
D.C. Diagnosis By Nicholas Florko The FDA’s ban on menthol in cigarettes clears a major regulatory hurdle
Exclusive By Rachel Cohrs White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process
Politics By Lev Facher A new nonprofit wants to rewrite the playbook for how the U.S. government funds science
Politics By Lev Facher Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on
Politics By Rachel Cohrs Medicare finalizes its restrictions on new Alzheimer’s drug, despite pressure from drugmakers
Politics By Rachel Cohrs Biden administration ramps up long Covid research efforts following criticism
Politics By Lev Facher ‘All the shrapnel that’s in my back’: Defiant Robert Redfield blasts former CDC directors for criticism during Covid-19
D.C. Diagnosis By Nicholas Florko Faced with high drug prices, seniors are abandoning cancer drugs at the pharmacy
Exclusive By Lev Facher Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist
Politics By Rachel Cohrs CMMI’s Fowler on health policy’s ‘stubborn challenges,’ her personal ties to medicine
Exclusive By Lev Facher Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence